Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Langer

Showing results (381-390 of 596) with videos related to

Pageof 60
Sort By:
World Neurosurgery|May 22, 2020
A Roadmap to Reopening a Neurosurgical Practice in the Age of COVID-19Randy S D'Amico, Griffin Baum, Yafell Serulle, et al.
The Journal of Liquid Biopsy|June 29, 2026
Erratum to "The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing" [J. Liq. Biopsy 12 (2026) 100461]Benjamin A Bleiberg, Dylan G Scholes, Lauren Reed-Guy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II studyM H Jagasia, C J Langer, D H Johnson, et al.
Journal of Experimental Therapeutics & Oncology|November 17, 2016
Intra-arterial cetuximab for the treatment of recurrent unresectable head and neck squamous cell carcinoma<sup>†</sup>Tristan Tham, Timothy G White, Shamik Chakraborty, et al.
Cancer Chemotherapy and Pharmacology|October 13, 2006
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)Roger B Cohen, Corey J Langer, George Rajan Simon, et al.
Surgical Neurology International|November 17, 2017
Suprasellar and third ventricular cavernous malformation: Lessons learned in differential diagnosis and surgical planningKay O Kulason, Julia R Schneider, Ralph Rahme, et al.
Journal of the American College of Radiology : JACR|January 31, 2009
ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Benjamin Movsas, Jeff Bradley, et al.
Journal of Neuro-Oncology|March 15, 2020
Correction to: Super selective intra‑arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are goingRandy S D'Amico, Deepak Khatri, Noah Reichman, et al.
World Neurosurgery|July 28, 2019
Rechallenging Recurrent Glioblastoma with Intra-Arterial Bevacizumab with Blood Brain-Barrier Disruption Results in Radiographic ResponseLukas Faltings, Kay O Kulason, Nitesh V Patel, et al.
Neurosurgery|November 22, 2019
Final Results of the Prospective Multicenter Excimer Laser-Assisted High-Flow Bypass Study on the Treatment of Giant Anterior Circulation AneurysmsAlbert van der Zwan, Peter Vajkoczy, Sepideh Amin-Hanjani, et al.
Pageof 60

Showing results (381-390 of 596) with videos related to

Sort By:
Pageof 60
World Neurosurgery|May 22, 2020
A Roadmap to Reopening a Neurosurgical Practice in the Age of COVID-19Randy S D'Amico, Griffin Baum, Yafell Serulle, et al.
The Journal of Liquid Biopsy|June 29, 2026
Erratum to "The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing" [J. Liq. Biopsy 12 (2026) 100461]Benjamin A Bleiberg, Dylan G Scholes, Lauren Reed-Guy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II studyM H Jagasia, C J Langer, D H Johnson, et al.
Journal of Experimental Therapeutics & Oncology|November 17, 2016
Intra-arterial cetuximab for the treatment of recurrent unresectable head and neck squamous cell carcinoma<sup>†</sup>Tristan Tham, Timothy G White, Shamik Chakraborty, et al.
Cancer Chemotherapy and Pharmacology|October 13, 2006
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)Roger B Cohen, Corey J Langer, George Rajan Simon, et al.
Surgical Neurology International|November 17, 2017
Suprasellar and third ventricular cavernous malformation: Lessons learned in differential diagnosis and surgical planningKay O Kulason, Julia R Schneider, Ralph Rahme, et al.
Journal of the American College of Radiology : JACR|January 31, 2009
ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Benjamin Movsas, Jeff Bradley, et al.
Journal of Neuro-Oncology|March 15, 2020
Correction to: Super selective intra‑arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are goingRandy S D'Amico, Deepak Khatri, Noah Reichman, et al.
World Neurosurgery|July 28, 2019
Rechallenging Recurrent Glioblastoma with Intra-Arterial Bevacizumab with Blood Brain-Barrier Disruption Results in Radiographic ResponseLukas Faltings, Kay O Kulason, Nitesh V Patel, et al.
Neurosurgery|November 22, 2019
Final Results of the Prospective Multicenter Excimer Laser-Assisted High-Flow Bypass Study on the Treatment of Giant Anterior Circulation AneurysmsAlbert van der Zwan, Peter Vajkoczy, Sepideh Amin-Hanjani, et al.
Pageof 60